158 related articles for article (PubMed ID: 21595650)
1. At last, a truly selective EP₂ receptor antagonist.
Birrell MA; Nials AT
Br J Pharmacol; 2011 Dec; 164(7):1845-6. PubMed ID: 21595650
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist.
af Forselles KJ; Root J; Clarke T; Davey D; Aughton K; Dack K; Pullen N
Br J Pharmacol; 2011 Dec; 164(7):1847-56. PubMed ID: 21595651
[TBL] [Abstract][Full Text] [Related]
3. Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor.
Birrell MA; Maher SA; Buckley J; Dale N; Bonvini S; Raemdonck K; Pullen N; Giembycz MA; Belvisi MG
Br J Pharmacol; 2013 Jan; 168(1):129-38. PubMed ID: 22747912
[TBL] [Abstract][Full Text] [Related]
4. EP2 and EP4 receptors mediate PGE2 induced relaxation in murine colonic circular muscle: pharmacological characterization.
Martinez-Cutillas M; Mañé N; Gallego D; Jimenez M; Martin MT
Pharmacol Res; 2014 Dec; 90():76-86. PubMed ID: 25461458
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
6. PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors.
Säfholm J; Dahlén SE; Delin I; Maxey K; Stark K; Cardell LO; Adner M
Br J Pharmacol; 2013 Feb; 168(4):794-806. PubMed ID: 22934927
[TBL] [Abstract][Full Text] [Related]
7. EP
Bradbury P; Rumzhum NN; Ammit AJ
J Cell Physiol; 2019 Jul; 234(7):11070-11077. PubMed ID: 30536718
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 represses interleukin 1 beta-induced inflammatory mediator output from pregnant human myometrial cells through the EP2 and EP4 receptors.
Mosher AA; Rainey KJ; Giembycz MA; Wood S; Slater DM
Biol Reprod; 2012 Jul; 87(1):7, 1-10. PubMed ID: 22517618
[TBL] [Abstract][Full Text] [Related]
10. Antagonising EP1 and EP2 receptors reveal that the TP receptor mediates a component of antigen-induced contraction of the guinea pig trachea.
Säfholm J; Dahlén SE; Adner M
Eur J Pharmacol; 2013 Oct; 718(1-3):277-82. PubMed ID: 24012781
[TBL] [Abstract][Full Text] [Related]
11. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
Walch L; Clavarino E; Morris PL
Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
Li YJ; Wang XQ; Sato T; Kanaji N; Nakanishi M; Kim M; Michalski J; Nelson AJ; Sun JH; Farid M; Basma H; Patil A; Toews ML; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295
[TBL] [Abstract][Full Text] [Related]
14. EP4 and EP2 receptor subtypes involved in colonic secretion in rat.
Mosa AS; Hansen MB; Tilotta CM; Bindslev N
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):214-21. PubMed ID: 18684231
[TBL] [Abstract][Full Text] [Related]
15. PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4).
Poloso NJ; Urquhart P; Nicolaou A; Wang J; Woodward DF
Mol Immunol; 2013 Jul; 54(3-4):284-95. PubMed ID: 23337716
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
Lawrence RA; Jones RL
Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
18. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
19. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.
Nataraj C; Thomas DW; Tilley SL; Nguyen MT; Mannon R; Koller BH; Coffman TM
J Clin Invest; 2001 Oct; 108(8):1229-35. PubMed ID: 11602631
[TBL] [Abstract][Full Text] [Related]
20. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.
Clarke DL; Giembycz MA; Patel HJ; Belvisi MG
Br J Pharmacol; 2004 Feb; 141(4):600-9. PubMed ID: 14744812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
